The Prevention of Postmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug

BioMed Research International - United States
doi 10.1155/2014/975927
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Denosumab for the Prevention of Osteoporotic Fractures in Postmenopausal Women

Health Technology Assessment
MedicineHealth Policy
2011English

Once-Yearly Zoledronic Acid in the Prevention of Osteoporotic Bone Fractures in Postmenopausal Women

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2008English

Parenteral and Oral Pharmacotherapy in Prevention of Osteoporotic Fractures in Postmenopausal Osteoporosis

Przeglad Menopauzalny
GynecologyEndocrinologyMetabolismObstetricsDiabetes
2013English

Vertebroplasty in Osteoporotic Spine Fractures: A Quality of Life Assessment

Canadian Journal of Neurological Sciences
MedicineNeurology
2005English

Disseminating Evidence From Health Technology Assessment: The Case of Tobacco Prevention

International Journal of Technology Assessment in Health Care
Health Policy
2006English

Results of Osteoporotic Treatment Drug After Periarticular Fracture of Hip

Journal of the Korean Fracture Society
2010English

Management of Osteoporotic Vertebral Fractures

International Journal of General Medicine
Medicine
2010English

Prevention of Osteoporosis-Related Fractures Among Postmenopausal Women and Older Men

CMAJ
Medicine
2009English

Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy